Ludmila Rivkin

TLR3 signaling in a hepatoma cell line is skewed towards apoptosis

H. Giladi, E. Galun, J. Rachmilewitz, 2007, Journal of cellular biochemistry.

Clinical evaluation (Phase I) of a human monoclonal antibody against hepatitis C virus: safety and antiviral activity.

Rifaat Safadi, N. Terrault, E. Galun, 2007, Journal of hepatology.

Toll‐like receptor 3 signaling attenuates liver regeneration

Elina Zorde-Khvalevsky, H. Giladi, E. Galun, 2009, Hepatology.

MicroRNA-mediated loss of ADAR1 in metastatic melanoma promotes tumor growth.

Gideon Rechavi, Victor G Prieto, Iris Barshack, 2013, The Journal of clinical investigation.

Small interfering RNA inhibits hepatitis B virus replication in mice.

H. Giladi, E. Galun, M. Ketzinel-Gilad, 2003, Molecular therapy : the journal of the American Society of Gene Therapy.

Specific genomic and transcriptomic aberrations in tumors induced by partial hepatectomy of a chronically inflamed murine liver

I. Steinfeld, E. Galun, O. Pappo, 2014, Oncotarget.

Mutant KRAS is a druggable target for pancreatic cancer

Y. Kopelman, R. Eliakim, A. Simerzin, 2013, Proceedings of the National Academy of Sciences.